https://www.selleckchem.com/products/ars-853.html
Novel inhalable and synergistic combination powder formulations of phage PEV20 and ciprofloxacin were recently developed to treat Pseudomonas aeruginosa respiratory infections. In the present study, we investigated the storage stability of these powders which comprised ciprofloxacin, lactose and L-leucine in mass ratios of 111 (Formulation A) or ciprofloxacin and L-leucine in 21 without lactose (Formulation . These powders were produced by spray drying, collected in polypropylene tubes and packed inside aluminium pouches which were he
Aimer
Commentaire
Partagez
